María Rios - Concepedia

Author

María Rios

Also Known As

Luis Fernando López-Cortés, M J Rios, M J Ríos, M José Ríos, M RIOS, M Rios, M. J. C. Rios, M. J. Rios, M. J. Ríos, M. José Ríos

331

Publications

9.9K

Citations

H-Index

178

Concepts

All Affiliations

Institut Bergonié Centre Léon Bérard Institut Gustave Roussy Centre Oscar Lambret Institut Paoli-Calmettes

About

María Rios is an author at Institut Bergonié specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	64	3.6K
2	Health Sciences	11	12	555
3	Natural Sciences	3	3	162
4	Engineering	1	1	20
5	Management	1	1	34

María Rios

152

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group Jean‐Yves Blay, Axel Le Cesne, Isabelle Ray‐Coquard, Journal of Clinical Oncology	2007	390
Improved survival using specialized multidisciplinary board in sarcoma patients Jean‐Yves Blay, Pauline Soibinet, Nicolas Penel, Annals of Oncology Surgical OncologySpecialized Multidisciplinary BoardMedicineCancer ManagementPrognosis	2017	349
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial X. Pivot, Gilles Romieu, Marc Debled, The Lancet Oncology Breast OncologyMedicineRandomised Phase 3Clinical TrialsBreast Cancer	2013	337
Surgery in reference centers improves survival of sarcoma patients: a nationwide study Jean‐Yves Blay, Charles Honoré, Eberhard Stoeckle, Annals of Oncology	2019	307
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial Axel Le Cesne, Isabelle Ray‐Coquard, Binh Bui, The Lancet Oncology Gastrointestinal OncologyMedicineGastroenterologyPathologyOpen-label Multicentre	2010	293
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial Olivier Mir, Thomas Brodowicz, Antoîne Italiano, The Lancet Oncology OncologyMetronomic TherapyClinical TrialsPharmacotherapyCancer Treatment	2016	276
Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer Miguel Martín, Miguel Ángel Seguí, Antonio Antón, New England Journal of Medicine	2010	208
The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection Sergio Vergara, A. Rivero, Alicia Gutiérrez‐Valencia, Clinical Infectious Diseases	2007	197
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group Nicolas Penel, Axel Le Cesne, Sylvie Bonvalot, European Journal of Cancer FibrosisSurgical PathologyPathologyNationwide Prospective CohortMedicine	2017	178
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs Ivana Maida, Marina Núñez, María Rios, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	166

Page 1